Literature DB >> 29496324

Surface marker profiles on lung lymphocytes may predict the mechanism of immune-mediated pneumonitis triggered by tumor-infiltrating lymphocytes in lung cancer patients treated with pembrolizumab.

Keishi Oda1, Kaori Kato1, Midori Nakamura1, Takanobu Jotatsu1, Shingo Noguchi1, Toshinori Kawanami1, Takashi Kido1, Kazuhiro Yatera2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29496324     DOI： 10.1016/j.lungcan.2018.02.012

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  6 in total

1.  Severe immune-related hyperthermia followed by immune-related pneumonitis with PD-1 inhibitor (sintilimab) in small cell lung cancer: A case report.

Authors:  Yi-Hui Li; Yang Zhou; Yuan-Yuan Liu; Guang-Ju Zhang; Lei Xiao; Na Li; Hai-Feng Qin; Jian-Gong Wang; Li Zhang
Journal:  Thorac Cancer       Date:  2021-05-05       Impact factor: 3.500

2.  VWCE as a potential biomarker associated with immune infiltrates in breast cancer.

Authors:  Qin Huo; Zhenwei Li; Siqi Chen; Juan Wang; Jiaying Li; Ni Xie
Journal:  Cancer Cell Int       Date:  2021-05-21       Impact factor: 5.722

3.  VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma.

Authors:  Lihua Zhang; Longhai Li; Yong Mao; Dong Hua
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

4.  Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.

Authors:  Masao Takemura; Mitsuru Motegi; Yuya Kuroiwa; Miki Itai; Kohei Taguchi; Kazue Umetsu; Megumi Uchida; Shunichi Kounoc; Mari Sato; Hiroaki Masubuchi; Aya Yamaguchi; Koichi Yamaguchi; Kana Ikeda; Junichi Nakagawa; Toshitaka Maeno
Journal:  Respir Med Case Rep       Date:  2021-02-02

5.  Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma.

Authors:  Jiayong Liu; Zhengfu Fan; Chujie Bai; Shu Li; Ruifeng Xue; Tian Gao; Lu Zhang; Zhichao Tan; Zhiwei Fang
Journal:  Ann Transl Med       Date:  2021-02

6.  ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.

Authors:  Tingting Deng; Yang Liu; Jialang Zhuang; Yizhe Tang; Qin Huo
Journal:  Front Oncol       Date:  2022-04-20       Impact factor: 5.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.